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Introduction
Platelets play complex roles in haemostasis and arterial thrombosis, rapidly adhering to subendothelial structures and to each other to generate a platelet aggregate which is stabilised by the local production of thrombin and subsequently fibrin 1 . Critical to this response is the surface exposure of aminophospholipids, particularly phosphatidylserine (PS), which promotes assembly of the tenase and prothrombinase complexes on the platelet surface. This platelet-dependent procoagulant activity therefore depends upon two major factors: (i) the degree of PS exposure and (ii) the surface area of membrane with exposed PS.
It is currently thought that a sustained rise in cytosolic Ca 2+ is required for exposure of PS on the extracellular leaflet of the plasma membrane, through activation of a non-specific phospholipid scramblase and inhibition of a PS translocase or flippase. Anoctamin-6 (gene ANO6 or TMEM16F) is identified as a key regulator of calcium-dependent PS exposure 2 , and loss-of-function mutations in anoctamin-6 have been shown in two Scott syndrome patients 3, 4 , who have aberrant calcium-dependent scramblase activity 5 . However the precise role played by anoctamin-6 is still unclear. It is possible that, like other members of the anoctamin family, it forms Ca 2+ -activated Clchannels 6 . Although much effort has gone into determining the molecular mechanisms regulating surface PS exposure, relatively little is known about the mechanisms by which platelet membrane surface area may be maximised. Possibly, Clentry may also be required for a change in membrane surface area, and this would be another distinct functional role for Clentry in potentiating platelet procoagulant activity.
Platelets have long been reported to transform in vivo to form balloons upon activation, and fibrin has been shown to fill the space between these balloon structures at wound sites [7] [8] [9] .
Platelet membrane ballooning has also been observed in vitro in platelets adherent to on the extracellular leaflet of the plasma membrane, through f activation of a non-s s spe pe peci ci cifi fi fic c c h phospholipid scramblase and inhibition of a PS translocase or flippase. Anoctamin-6 (gene ANO6 O6 O6 o o or r r TM TM TMEM EM M16 16 16F) is identified as a key regul ul lat at ato o o F F r of calcium-depende de dent n n PS exposure 2 , and o o oss s s-of-functi ion n n m mut t tat at at o io ons ns ns i i in n n an an anoc oc octa ta tami mi min-6 ha h h v v ve bee ee en sh sh how ow own n n in i i t two wo wo S S Sco co cott syn n ndr dr drom om me e e pa pa pati ti tien en nts ts ts 3 3, 3, 4 4 4 , wh wh who o o ha h h ve abe be berran n ant t t cal lci iu i m-de de depe pe pend d den e e t sc c cramb mb mbla l se e a a activ iv vi it ity y 5 . . . Ho Ho How w weve ve ver r r th h he e pr rec ec ecis i i e ro o ole le le pl lay y yed by by by an an anoc oc octa ta tami mi min n n-6 6 6 is is is s s sti ti till ll ll unc nc ncle le lear ar ar. It It It i i is s s po po poss ss ssib ib ible le le t t tha ha hat t t, li li like ke ke o o oth th ther er er m m mem em embe be bers rs rs o o of f f th th the e e an an anoc oc octa ta tami mi min n n fa fa fami mi mily l ly, it it it 4 immobilised collagen [10] [11] [12] . However, it is not clear whether this striking morphological change is analogous to apoptotic blebbing in other cell types [13] [14] [15] . Attempts to assess ballooning in platelets have been limited by the methods of investigation, imaging resolution 10 and the fragility of the balloon structure which often results in its loss or significant deformation 11 .
Here we hypothesised that platelet ballooning was important to markedly increase the surface area of exposed membrane, and exposed PS, thereby enhancing the local procoagulant response 10, 16, 17 . We used detailed dynamic imaging approaches to visualise thrombin generation on platelet membrane surfaces and to understand the mechanisms regulating ballooning. This study revealed that the key mechanism involves fluid entry, accompanied by the genesis of a novel spread membrane structure in a process we have termed 'procoagulant-spreading'. Unlike conventional lamellipodial spreading, this form of spreading yields procoagulant surfaces, and rapidly breaks up by multiple coalescences to form numerous procoagulant microvesicles.
Ballooning and procoagulant-spreading are therefore linked processes which are likely to contribute to hemostatic responses in vivo.
Methods
Written informed consent was obtained in accordance with the Declaration of Helsinki.
Human blood was obtained from healthy drug-free volunteers under Local Research Ethics approval (E5736). The UK Scott patient blood was obtained with NHS Research Ethics Committee approval, and has been described. This Scott patient is a compound TMEM16F heterozygote, IVS6 + 1G A, resulting in exon 6 skipping. Another mutation in this patient, (c.1219insT) causes premature translation termination and defective expression of TMEM16F 4, 18 .
Materials
Details of materials used are given in Supplementary files. novel spread membrane structure in a process we have termed 'procoagulant-spre e ead ad adin in ing' g' g'. . 5
Platelet-rich plasma preparation
Blood drawn from healthy human volunteers was anticoagulated with 0.4% trisodium citrate and acidified with 16% acid citrate dextrose (85 mmol/L trisodium citrate, 71 mmol/L citric acid, 111 mmol/L glucose). Platelet-rich plasma (PRP) was obtained by centrifugation at 180 g for 17 min.
Washed human platelet preparation
PRP was centrifuged at 650 g for 10 min in the presence of 10 mol/L indomethacin and 0.02 U/mL apyrase, and resuspended in HEPES-Tyrode's buffer modified with 0.1% (w/v) glucose, 10 mol/L indomethacin, and 0.02 U/mL apyrase. Sodium and chloride free HEPES-Tyrode's buffers were prepared by replacing Na + and Clwith equimolar N-methyl-D glucamine and gluconate, respectively.
Live cell confocal microscopy
Washed human platelets were pre-incubated (10 minutes) with calcium dye Fluo-4 AM and Alexa Fluor 568 annexin-V conjugate (1% V / V ). Hyperosmolar Tyrodes' was prepared by adding 40 mmol/L sucrose to HEPES-Tyrode's buffer. MatTek dishes were pre-coated with collagen (20 μg/mL) and aliquots of platelet suspensions were added (2x10 7 cells/mL), supplemented with 1 mmol/L CaCl 2 . Changes in relative fluorescence intensity (F/F 0 ) over time were monitored.
Details of confocal microscopy are given in Supplementary files.
Measurement of platelet thrombin generation
PRP was incubated with fluorogenic thrombin substrate, Z-GGR-AMC (450 μmol/L). PRP was re-calcified and thrombin generation initiated with 5 pmol/L tissue factor. Thrombin substrate was measured on platelet membrane surfaces and traces for single platelets and platelet aggregates were converted into first-derivative curves. gluconate, respectively. 
Live cell confocal microscopy

In vitro and in vivo thrombosis assays
Details of in vitro and in vivo thrombosis assays are given in Supplementary files.
Statistical analysis
Data were analyzed using GraphPad Prism 6 (San Diego, CA) and presented as interleaved box plots with whiskers showing min to max values and interquartile ranges. We determined statistical significance by the Friedman test, followed by Dunn's multiple comparison test or by Wilcoxon Signed Rank Test. p<0.05 (*) or p<0.01 (**) was considered significant.
Results
Spatiotemporal dynamics of platelet membrane ballooning and phosphatidylserine exposure
Upon interaction with sub-endothelial matrix platelets are transformed into balloon-like structures as part of the haemostatic response [7] [8] [9] [10] . To obtain more temporal and dynamic insight into platelet ballooning, we used phase-contrast and confocal live cell imaging microscopy techniques to study platelet adhesion and ballooning on a collagen-coated surface. In the early phases of contact with collagen, platelets formed small, retractable membrane blebs (Figure 1A , image 2-7, blue arrows).
Statistical analysis
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However, in many platelets, one of these blebs can swell to become a balloon ( Figure 1A , image 10, yellow arrow), which ranged between 1 -6 μm in diameter and typically did not retract ( Figure   1A , Movie S1). We identified three distinct phases leading to balloon formation, which we termed phases Ph 1 , Ph 2 and Ph 3 (Figure 1B) . Ph 1 was characterised by blebbing (membrane protrusion 1 μm) ( Figure 1A and B , images 1-5). During Ph 2 , the membrane of non-retracted blebs rapidly expanded (images 6-8) and in Ph 3 , the expansion plateaued (images 9-10). Initiation of ballooning was typically by 5 min after adhesion of the platelet to collagen fibre, and progressed rapidly to phase 3 by a further 5 min. Importantly, we observed platelet ballooning in vivo, in a mouse thrombus formation model ( Figure S1A) , consistent with previous observations [7] [8] [9] . Ballooning also occurred in human thrombi, as shown in in vitro flow studies (Figure S1B, C). Interestingly there was no ballooning in platelets adherent to von Willebrand factor in the presence of botrocetin, suggesting agonist specificity of the response.
A 3D recontruction showed that the platelet body and the balloon membrane bound labelled annexin-V, demonstrating PS exposure and generation of a procoagulant surface 5, [19] [20] [21] ( Figure 1C , Movie S2). Annexin-V binding was characterised by two stages: Initially, a low level (F/F 0 = 1.3-1.5) of annexin-V accumulated on the membrane of the platelet body alone ( Figure 1D , images 1-5), followed by annexin-V binding to the balloon as well (Figure 1D , images 7-10, Movie S3). Importantly, PS externalisation did not temporally correspond with membrane ballooning (Figure 1E&F ), suggesting a distinction between the mechanisms underlying these two events. Furthermore, integrin IIb 3 was activated at an early time point prior to ballooning, but was sustained and localised just to the platelet body (Figure 1G, H) .
Thrombin is generated on the ballooned surface of human platelets adherent to collagen
To demonstrate that ballooned platelets support a procoagulant response, we visualised the occurred in human thrombi, as shown in in vitro flow studies (Figure S1B, C). Inte te tere re rest st stin in ingl gl gly y y th th the e ere was no ballooning in platelets adherent to von Willebrand factor in the presence of botrocetin, ugg g ges es esti ti ting ng ng a a ago g g ni i ist st st specificity of the response. Platelet ballooning may therefore be important for the procoagulant response, by increasing the available surface area for recruitment of the tenase and prothrombinase complexes (Figure S2 ).
Ballooned and procoagulant-spread (BAPS) platelets
Using 4D imaging, we observed four distinct platelet phenotypes adherent to collagen ( Procoagulant-spreading, in BAPS platelets, was only clearly identifiable by visualising annexin-V just above (between 0 and 0.75 m) the collagen-coated surface (Figure 3A&B , in red, Movie S4). The area covered by procoagulant-spread platelets is generally much greater than by conventionally spread platelets and can extend to around 20 m ( Figure 3A) . BAPS platelets constitute a distinct subpopulation of adherent platelets, and this report is the first characterisation of these structures.
Platelet ballooning may therefore be important for the procoagulant response, by i i inc nc ncre re reas as asin in ing g g th th the available surface area for recruitment of the tenase and prothrombinase complexes ( Figure S2 ). Ballooning and procoagulant-spreading are synchronised events 4D live-cell imaging showed balloon formation started within 4 min after platelet adhesion and reached a maximal diameter by 9-10 min, as visualised by annexin-V binding (Figure 4A&B ).
Ball loo oo oone ne ned d d an an and pr pr proc o oagulant-spread (BAPS) p p pla la late t t lets
Procoagulant membrane spreading followed membrane ballooning after a 1-2 min delay ( Figure   4A -Ci) and both were temporally correlated (Figure 4Ci, Movies S5&S6) . Only a small proportion of platelets (approx. 10%) ballooned without procoagulant-spreading (BNS; Figure   4Cii ), and we did not observe procoagulant-spreading without ballooning These data suggest that ballooning is likely to be required for procoagulant-spreading, but not vice versa. In this experiment, after adhesion of platelets to collagen for 1 hr, the mean relative proportions of platelets were CSNB (27.4%), BNS (10.4%), BAPS (50.0%), NBNS AnxV -(5.9%), and NBNS AnxV + (6.3%) (Figure 4Cii) .
BAPS platelets showed a punctate or cobble-stone annexin-V staining pattern ( Figure   4A&B ). In addition, BAPS platelets released microvesicles in a time-dependent manner (Suppl. Figure S3 ) and scanning electron microscopy showed the cobble-stone appearance to be microvesicles formed from BAPS platelets after 1 h adhesion (Figure 4D-F) . This was clearly distinct from the CSNB platelet ( Figure 4E ). We therefore suggest that procoagulant-spreading forms the basis for microvesicle formation and release upon adhesion of platelets to surfaces.
Inhibition of actomyosin promotes membrane ballooning whilst blocking procoagulantspreading
To determine the role of the actin cytoskeleton in ballooning and procoagulant-spreading, platelets were incubated with modulators of actin polymerisation or myosin motor activity. (Figure 5Aii, Figure S3 ). Similar results were found with platelets pre-treated with cytochalasin-D or Y27632. However, whilst enhancing ballooning, blebbistatin, cytochalasin-D and Y27632 inhibited spreading, and therefore formation of the BAPS morphology, so that platelets were restricted to the BNS phenotype (Figure 5Aii ). Platelets treated with jasplakinolide, to promote actin polymerisation 23 , did not show any membrane ballooning or spreading. The data indicate that actin polymerisation and myosin contraction negatively control membrane ballooning. Inhibition of procoagulant-spreading using cytochalasin D also resulted in diminished thrombin generation ( Figure 5B ).
Probing live platelets with AlexaFluor-350 phalloidin showed staining in the spread membranes of BAPS platelets (Figure 5C ), indicating that their membrane integrity was likely to be compromised and that the balloons were actin-rich (see also Movie S7). In contrast, CSNB platelets were phalloidin negative.
Platelet ballooning involves microtubule disruption at the exit point of the protrusion
Transmission electron microscopy images of platelets in the expansion phase (Ph 2 ) of ballooning revealed a neck structure that delineated the balloon from the main platelet body (Figure S4A ;
yellow arrows), beneath which lay a disrupted microtubule ring structure, shown in detail by TEM tomography (Figure S4Aiii , green arrows; Movie S8). Significantly, there was no microtubule architecture present in Ph 3 balloons ( Figure S4B ). In the later phases of balloon formation, the integrity of the membrane becomes compromised, since it becomes leaky to two low molecular weight dyes, calcein and propidium iodide (data not shown).
Platelet ballooning and procoagulant-spreading requires salt and water entry
The rapid growth of the platelet balloon suggested that it may be driven by fluid entry. Our data Probing live platelets with AlexaFluor-350 phalloidin showed staining in th th the e e sp sp spre re read ad ad membranes of BAPS platelets (Figure 5C ), indicating that their membrane integrity was likely o be e e co co comp mp mpro ro romi m s s sed d d and that the balloons were ac ac cti ti tin n n-rich (see also Movi vi vie e e S7). In contrast, CSNB p pl plat t telets were p p ph h hal lloi oi oid d din n n ne ne nega ga gati ti tive ve e.
Pl Pl lat at atel el e et bal l llo lo loon nin in ing in n nv vo v lves es s m m micro ro rot tu tubu bu bule d d dis s srup pt p i i ion n n a a at t the he he e e exi xi it po po poin nt o of t t the he he pro o otr r rusi ion
Tr Tr Tran an ansm sm smis is issi si sion on on e e ele le lect ct ctro ro ron n n mi mi micr cr cros os osco co copy p py i i ima ma mage ge ges s s of of of p p pla la late te tele le lets ts ts i i in n n th th the e e ex e expa pa pans ns nsio io ion n n ph ph phas as ase e e (P (P (Ph h h f f f 2 ) ) ) of of of b b bal al allo lo loon on onin in ing g g g 11 showed a 1.6 ± 0.02 fold increase in [Cl -] cyt after 5 min contact with collagen ( Figure 6A&B) , which was absent in Clfree medium (not shown). In similar experiments, we recorded transient Na + entry during platelet adherence to collagen (Figure 6C&D) , which was absent in Na + free medium (not shown). The percentage of adhered platelets that ballooned ( Figure 6E ) and underwent procoagulant-spreading (BAPS, Figure 6F ) was significantly attenuated in media lacking Clor Na + ions. Interestingly, the peak change and half-life of annexin-V binding were significantly reduced under these conditions (Figure S3 ). It is likely that Clentry was substantially mediated by calcium-activated chloride channels (CaCC) since the inhibitor of these channels, CaCCinh-A01, induced similar effects to removal of extracellular Cl - (Figure 6E and F).
To assess whether water entry was required for ballooning, we increased extracellular osmolality, using sucrose, by 40 mmol/L, which significantly attenuated both ballooning ( Figure   7A ) and procoagulant spreading (BAPS, Figure 7B ), but not blebbing ( Figure 7A ).
Furthermore, mean balloon diameter was attenuated in the small proportion of platelets able to balloon ( Figure S3A) . Acetazolamide has been shown to block aquaporin water channels 24 , and it induced a characteristic retraction of the ballooning membrane ( Figure 7A ) and attenuated membrane accumulation of annexin-V (Movie S9). Importantly, there was also a marked reduction in formation of BAPS platelets (Figure 7B ), suggesting a requirement for water entry in procoagulant-spreading.
In addition, acetazolamide and hyperosmotic challenge significantly reduced PS exposure and thrombin generation on the platelet surface ( Figures 7C&D, S3B and Movies S9, 10). The mean intensity of thrombin substrate per unit membrane area was similar in BAPS and BNS platelets (Figure 7E ), suggesting that the greater thrombin generation seen in controls was due to increased membrane surface area provided by ballooning and procoagulant-spreading.
To assess whether water entry was required for ballooning, we increased ex ex extr tr trac ac acel el ellu lu lula la lar r r osmolality, using sucrose, by 40 mmol/L, which significantly attenuated both ballooning ( Figure   7A ) ) ) an an and d d pr pr proc oc ocoagu gu gula l l nt spreading (BAPS, Blocking water entry and ballooning significantly reduces in vivo thrombus formation.
Mice were treated by bolus intravenous administration of acetazolamide (7 mg/kg) and carotid artery damage was induced by application of FeCl 3 (10% v / v ). Accumulation of platelets, labelled with DyLight 488-antiGp1b , was visualised by video epifluorescence microscopy.
Whereas control mice showed rapid and sustained accumulation of platelets in a growing and eventually occlusive thrombus, mice treated with acetazolamide were markedly spared from this event (Figure 8) . Balloon-enhanced local generation of thrombin will therefore likely form a positive feedback system to further activate platelets and promote coagulation.
Discussion
Platelets are the surveillance cells of the vascular system, detecting vessel damage events and acting as the early and rapid response system to address the damage they recognise. They rapidly adhere to sub-endothelial matrix collagen, recruit more platelets to form an aggregate and stabilise the structure by initiating blood coagulation. This procoagulant activity depends on the surface exposure of negatively charged aminophospholipids, particularly phosphatidylserine (PS), which binds the tenase and prothrombinase complexes. The dynamics of platelet membrane transformation therefore underpin the coagulant response. Previous studies have shown that platelets are able to undergo both membrane blebbing and ballooning upon activation [7] [8] [9] [10] [11] , and that platelet balloon formation is part of the normal hemostatic response. In particular the studies of Wester et al., 7, 8 used a template bleeding technique to induce acute wounds to human skin, and excised the wounds at various time periods after wounding. Using histological and electron microscopic approaches they showed the existence of platelet balloons within the structure of the associated thrombus. Importantly they showed that fibrin was deposited in the margins between
Platelets are the surveillance cells of the vascular system, detecting vessel damage events and acting ng ng a a as s s th th the e e ea e rl l ly y y and rapid response system to ad Consistent with this, we demonstrated that activated factor V and X are bound to ballooned platelet membranes (Fig. S2) . We have determined the molecular regulation of these events, and revealed in real time the formation of a novel ballooned and procoagulant-spread (BAPS) platelet phenotype in a process we termed procoagulant-spreading. The balloon and procoagulant-spread structures are functionally linked and both contribute to the local generation of thrombin. BAPS platelets break into a multitude of procoagulant microvesicles, and this process may form a major route for generation of platelet-derived microvesicles which contribute to local hemostasis but with potential for pathological roles in various cardiovascular diseases 25 .
While previous studies had described platelet membrane ballooning in some detail 7, 8, 10, 11, 26 , this is the first report of coordinated membrane ballooning and procoagulant-spreading.
Platelets with characteristics similar to the ballooned platelets seen here have been reported, particularly COATED and SCIP platelets 18, 26 . However, there are clear differences, since platelets in this study showed sustained integrin IIb 3 activation (Figures 1G,H & S2) and transient increase in cytosolic calcium (data not shown). Furthermore, data in Figure S2 and S4b show that the balloon retains some of the molecular and subcellular components of the platelet from which it was derived, including various surface receptor markers and mitochondria.
The timing and localisation of PS exposure in platelets indicates that it does not appear until ballooning is well under way, suggesting that PS exposure is not a requirement for ballooning. Rather, platelet balloons result from physical disruption to the circumferential microtubule, accompanied by an increase in internal hydrostatic pressure provided by a coordinated Na + , Cland water entry mechanism, which inflates the balloon. By contrast, membrane blebbing analogous to that seen in cancerous cells is reversible and occurs While previous studies had described platelet membrane ballooning in som m me e e de de deta ta tail il il independent of fluid entry mechanisms 27 . It is possible that Na + may enter through non-selective cation channels, such as TRPC6 28 , or by Na + /Ca 2+ exchange. For Cl -, anoctamin (TMEM16)
genes are key components of calcium-activated chloride channels, (CaCC) [29] [30] [31] . Anoctamin-6 is a CaCC 6, 32 which functionally couples to TRPC channels 33 . Salt may therefore enter through regulated pathways, providing an osmotic drive for water entry and ballooning. The role of calcium in these events is pivotal since blockade of calcium entry or release from intracellular stores abolished ballooning and procoagulant-spreading, but not lamellipodial spreading (data not shown). A rise in cytosolic free Ca 2+ may therefore trigger CaCC opening 6 and allow chloride entry 34 . Interestingly, the rise in cytosolic Na + and Clions concentrations are predominantly in the platelet cell body, rather than the balloon (Figure 6) . A possible explanation is that the major volume change occurs in the balloon, and not in the cell body.
Likely, all increases in ion concentration in the balloon are continuously being diluted through entry of water. Related to this, we have never observed balloons to continue to grow or to burst, but always observe them reaching a plateau size. We suggest that this is likely to be a product of this transient increase in ion permeability leading to a self-limiting water entry, constraining the balloon to a steady-state sustained volume.
Scott syndrome is extremely rare and patients show a bleeding disorder associated with defective expression of TMEM16F and a resultant defect in microvesicle formation and exposure of PS 5, 35 . Our observations show that platelet ballooning is also markedly impaired in this syndrome (Figure 1C) . It is possible that TMEM16F provides the critical mechanism driving ballooning, through regulated ion influx followed by water, and that the membrane stretching lowers the activation energy required for scrambling of membrane phospholipids and movement of inner leaflet PS to the outer leaflet.
predominantly in the platelet cell body, rather than the balloon (Figure 6) . A poss ss ssib ib ible le le explanation is that the major volume change occurs in the balloon, and not in the cell body. & 7) also blocked procoagulant-spreading and microparticle generation ( Figure S3 ). Agents that inhibit procoagulant-spreading independent of ballooning, such as blebbistatin, cytochalasin-D or Y27632, also largely inhibited microparticle formation ( Figure S3) . It is therefore likely that all these events are functionally linked, and sequential, from ballooning to procoagulant-spreading to microparticle formation (Movies S5&S6). It is interesting to note that endothelial PS exposure has recently been shown to play a major role in thrombin generation 36 . However, it is possible that procoagulant-spreading may also allow platelets to contribute to coagulation over a much wider surface area than just the platelet 'cell body', which may explain any apparent discrepancy with Ivanciu et al. (2014) .
Our data would also suggest that as the hydrostatic pressure in the platelet cell body rises, it is able to sustain this increase in pressure due to the intact cytoskeleton of the cell. However, once a weakness in the cytoskeleton develops, the membrane rapidly inflates to generate the balloon. This leaves further questions, such as the molecular nature of the ion and water channels, and whether disruption of the cytoskeleton is a tightly coordinated event. The fact however that acetazolamide is able to markedly diminish in vitro ballooning, and also act to generation (Figure S3 ). Agents that inhibit procoagulan t-spreading independent of of of b b bal al allo lo loon on onin in ing, g g uch as blebbistatin, cytochalasin-D or Y27632, also largely i n nhibited microparticle formation Figu gu gure re re S S S3 3 3). ). ). It i i is th t t erefore likely that all these ev ev even en ents are functionally li li link n n ed, and sequential, fr fr from m m balloonin ing g g to o p p pro ro roco co coag ag agul ul ulan an ant t t-sp sp spre r r ad a a i ing to t t mic cro o opa a art rt rtic ic icle le le f f for orma ma mati ti tion on on ( ( (M Movi vi ies es es S S S5& 5& 5&S6 S6 6) ) ). It It It i i is s s n n nte te t re re resting to to to not t te that t t e e endot t the he heli l l al P P PS ex ex expo po p s su sur r re ha as rec c ce en ently y y be be been n n s sh show ow own to p p pla a ay y y a ma ma major r r r role in n h h hro ro romb mb mbin in in g g gen en ener er erat at atio io ion n n 36 36 In conclusion, this study has uncovered the molecular mechanisms that control dramatic platelet membrane ballooning and revealed a novel procoagulant-spread membrane structure, upon platelet activation by collagen. The events are mechanistically coupled and are likely to amplify the procoagulant responses at wound sites. They also suggest a route by which platelets generate microparticles upon contact with collagen. The mechanism of membrane ballooning shown here, which involves salt and water entry into the cells, may lead to new therapeutic directions for the control of thrombus formation in vivo. ( (B B B , a a and nd nd s s see ee ee 
Electron microscopy of mouse carotid artery
The carotid artery was carefully excised and added to 2.5% glutaraldehyde in 0.1 mol/L sodium cacodylate buffer for 1 h. The tissue was post-fixed with 1% osmium tetroxide in sodium cacodylate buffer for 1 h, stained with 3% uranyl acetate in deionised water for 30 min and dehydrated through a graded series of ethanol (70%, 80%, 90%, 96%) followed by three washes in 100% ethanol. The ethanol was replaced with propylene oxide prior to incubation in a 1:1 mixture of propylene oxide and Epon for 24 h. The propylene oxide was left to evaporate for 3 h before the tissue was added to fresh Epon which was hardened for 72 h at 60°C. The artery was sectioned at a thickness of 70 nm.
Correlative light-electron microscopy of platelets
Platelets were seeded into live cell imaging dishes (MatTek) with an etched grid pattern in the glass. Upon completion of fluorescence imaging, the location of the platelets of interest on the grid was noted. Platelets were fixed with 2.5% glutaraldehyde in 0.1mol/L sodium cacodylate buffer (pH7.4) for 30 minutes. Platelets were post-fixed with 1% osmium tetroxide in sodium cacodylate buffer for 30 minutes and stained with 3% uranyl acetate in deionised water for 30 minutes. Platelets were dehydrated through a graded series of ethanol (70%, 80%, 90%, 96%) followed by three washes in 100% ethanol. Platelets were then embedded in pure Epon for 2 hours before being replaced with fresh Epon and hardened for 48 hours at 60°C. The etched coverslip was removed by first submerging in liquid nitrogen and then plunging into boiling water. This process was repeated until the coverslip could be lifted away from the resin. The resin was then trimmed down to the area of interest and sectioned at a thickness of 250 nm. Transmission electron microscopy (TEM) images were acquired on an Eagle 4k x 4k CCD camera attached to an FEI Tecnai 12, 120kV BioTwin Spirit.
Transmission EM Tomography Sections were exposed to fiducial markers (10 nm gold particles) on both sides. A dual axis tilt series was acquired using an FEI Tecnai 20, 200kV TEM using a minimum angular range between -60° and +60°, acquiring images at 1° increments. The two tilt series were combined using IMOD reconstruction software.
In vitro thrombosis assay
Flow chambers (Vena8™ biochip) were coated with 50 μg/mL fibrillar collagen for 2 h at 4°C. Chambers were then blocked with 2% fatty acid-free BSA (Sigma Aldrich) overnight at 4°C. Human blood was drawn from healthy volunteers, under local ethics committee agreement and after fully informed consent. Blood was taken into 4% citrate (1:10 v/v) and supplemented with 2 units/mL heparin (Sigma Aldrich) and 40 μmol/L PPACK (Calbiochem). Blood was labelled with 2 μmol/L DiOC 6 (3,3′-dihexyloxacarbocyanine iodide) for 10 min in the dark. Immediately prior to being passed through the flow chamber, 6.6 mmol/L CaCl 2 and 6.6 mmol/L MgCl 2 were added. Blood was passed through the flow chamber at a rate of 1000 s -1 for 5 min. The flow chamber was washed for 5 min with HEPES-Tyrode's buffer (10 mmol/L HEPES pH 7.2, 145 mmol/L NaCl, 3 mmol/L KCl, 0.5 mmol/L Na 2 HPO 4 , 1 mmol/L MgSO 4 ) to remove excess red blood cells. The chamber was visualised by confocal microscopy.
Ferric chloride carotid injury model in mouse
In vivo thrombus formation assays were performed as described here. Mice were bred and experimental procedures performed under UK Home Office licence PPL30/2908, held by AWP. Mice were anaesthetised with ketamine 100 mg/kg (Vetalar V, Pfizer) and 10 mg/kg xylazine (Rompun, Bayer). Acetazolamide or control vehicle was administered by intravenous bolus and platelets were labelled by intravenous administration of 100 mg/kg Dylight-488 conjugated anti-GPIbβ antibody, 10 min prior to induction of thrombosis. Right carotid arteries were exposed and 2x1 mm 15% ferric chloride-soaked filter paper was placed on the arterial adventitia for 3 min. Time-lapse microscopy of the injury site for 20 min was performed and images processed using ImageJ. Background fluorescence values measured upstream of the injury site were subtracted from thrombus-specific fluorescence and data expressed as integrated densities. 
SUPPLEMENTARY FIGURES
Figure
Figure S2: Ballooned human platelets' membrane expressed coagulation markers.
Platelets allowed to undergo adhesion and full membrane ballooning (phase 3) over collagencoated surfaces. Cells were then stained for expression of surface markers with anti FVa, anti FXa, anti-CD41, anti-GP1b, anti-P-selectin and anti-PAR1 and counterstained with Alexa568-AnxV as indicated. Oregon green conjugated human fibrinogen was also used to stain platelets as indicated. Scale bar = 3µm. Data were obtained from platelets analysed from 3 human donors. 
SUPPLEMENTARY MOVIES
Movie S1 Platelet membrane ballooning is a consequence of adhesion to collagen; related to Figure 2 . Confocal phase contrast images of human platelet adhering to fibrillar collagen were captured at the rate of 1 frame per 4 seconds. Confocal images were acquired using a Perkin Elmer Ultra-VIEW ERS 6FE confocal. Movie was created at 24 frames per second using Volocity 6.3 software.
Movie S2
Membrane balloon increases platelet procoagulant surface; related to Figure 2 . Movie is a 3D visualisation of a ballooned human platelet, showing copious accumulation of annexin-V (in red) on both platelet body and inflated/ballooned membrane. Images were acquired by Perkin Elmer Ultra-VIEW ERS 6FE confocal system. Rotated 3D reconstruction of image sections was performed as described in methods using Volocity 6.3 software.
Movie S3
Spatio-temporal dynamics of the early procoagulant response associated with collagen induced human platelet ballooning; related to Figure 2 . Fluo-4 (in green) and annexin-V (in red) were used to monitor calcium mobilisation and membrane exposure of phosphatidylserine in real time, respectively. Images were captured as described in methods at a frame per 4 seconds, using a Perkin Elmer Ultra-VIEW ERS 6FE confocal system. Movie was created at 24 frames/second using Volocity 6.3 software.
Movie S4
Ballooned and procoagulant-spread (BAPS) platelets are a distinct subpopulation of human platelet on collagen sites; related to Figure 3 . Fluo-4 (green) and annexin-V (red) were used to label intracellular calcium and externalised phosphatidylserine. A z-axis view is shown as image acquisition mode is switched from phase contrast to fluorescence mode. Images were captured at a frame per 4 seconds, using a Perkin Elmer Ultra-VIEW ERS 6FE confocal system. Video rendition was done using Volocity 6.3 software.
Movie S5
Ballooning and procoagulant-spreading visualised (X-Y) orientation; related to Figure  4 . A 4-dimensional (4-D: xyz-t) reconstruction of human platelets adherent on collagen shows real time membrane dynamics in the X-Y axis. Images were captured using a Perkin Elmer Ultra-VIEW ERS 6FE confocal system. Images are superimposed annexin-V (red) and DIOC 6 (green) 3D re-constructions at selected time-points previously indicated. Movie was created using Volocity 6.3 software.
Movie S6
Ballooning and procoagulant-spreading visualised in (X-Y-Z) orientation; related to Figure 4 . A 4-dimensional (4-D: xyz-t) reconstruction of human platelets adherent on collagen showing real time membrane dynamics in the X-Y-Z axis. Images were captured using a Perkin Elmer Ultra-VIEW ERS 6FE confocal. Images are superimposed annexin-V (red) and DIOC 6 (green) 3D re-constructions at selected time-points previously indicated. Movie was created using Volocity 6.3 software.
